Merck KGaA's Backed Outlook Suggests Recovery Despite Subdued Orders -- Market Talk
1558 GMT - Merck KGaA's backed full-year guidance implies improvement in the second half of the year despite subdued demand at its life-science segment in the first quarter, Stifel analysts say in a n
Merck KGaA's Detailed Guidance, Results Support Outlook -- Market Talk
0807 GMT - Germany's Merck KGaA gave quantitative 2024 guidance for the first time and this, together with first-quarter results, affirms its expectation of a return to organic growth in net sales and
Merck KGaA Non-GAAP EPS of €2.06, Revenue of €5.12B; Updates FY24 Outlook
Merck KGaA Confirms Outlook After Drop in Sales, Earnings
By Adria Calatayud Germany's Merck KGaA confirmed and detailed its guidance for 2024 after it reported lower sales and earnings for the first quarter, hit by inventory reductions at its life-science
Merck KGaA 1Q Sales EUR5.12B
Merck KGaA 1Q Sales EUR5.12B
Merck KGaA Backs 2024 View
Merck KGaA Backs 2024 View
Merck KGaA CEO Says Acceleration Expected in 2H, Especially in Life Science
Merck KGaA CEO Says Acceleration Expected in 2H, Especially in Life Science
Merck KGaA Sees 2024 Ebitda Before One-Time Items of EUR5.7B-EUR6.3B
Merck KGaA Sees 2024 Ebitda Before One-Time Items of EUR5.7B-EUR6.3B
Merck KGaA Sees 2024 Organic Net Sales Growth of 1% to 5%
Merck KGaA Sees 2024 Organic Net Sales Growth of 1% to 5%
Merck KGaA 1Q After-Tax Profit EUR699M
Merck KGaA 1Q After-Tax Profit EUR699M
Merck KGaA Says Inventory Destocking in Life Science Continues
Merck KGaA Says Inventory Destocking in Life Science Continues
Merck KGaA Says Healthcare Delivered Strong Performance in 1Q
Merck KGaA Says Healthcare Delivered Strong Performance in 1Q
Merck KGaA Says Electronics Sales, Earnings Rose Organically in 1Q
Merck KGaA Says Electronics Sales, Earnings Rose Organically in 1Q
Merck KGaA (ETR:MRK) Is Due To Pay A Dividend Of €2.20
Merck Shareholders Approve Dividend of EUR2.20 Per Share At AGM
Merck Shareholders Approve Dividend of EUR2.20 Per Share At AGM
Merck Shareholders Elect New Supervisory Board at AGM
Merck Shareholders Elect New Supervisory Board at AGM
Shareholders Will Most Likely Find Merck KGaA's (ETR:MRK) CEO Compensation Acceptable
MERCK KGAA SPON ADR EACH REPR 0.2 ORD SHS To Go Ex-Dividend On April 29th, 2024 With 0.47297 USD Dividend Per Share
April 6th - $MERCK KGAA SPON ADR EACH REPR 0.2 ORD SHS(MKKGY.US)$ is trading ex-dividend on April 29th, 2024. Shareholders of record on April 30th, 2024 will receive 0.47297 USD dividend per share
Merck KGaA to Open $326 Mln Pharmaceutical Plant in South Korea to Expand in Asia
By David Sachs Merck KGaA will spend more than 300 million euros ($326 million) on a pharmaceutical plant in South Korea as part of its strategy to expand in Asia. The German drug-and-chemicals comp
Provell Pharmaceuticals and Mark Cuban Cost Plus Drug Company Bring Leading Hypothyroid Drug, Euthyrox, to U.S. Patients at Low-Cost Prices Through Direct-to-Consumer Model
HONEY BROOK, Pa., March 12, 2024 /PRNewswire/ -- Provell Pharmaceuticals, a healthcare company that distributes world-class, branded drugs at generic prices by eliminating middlemen markups, today an
No Data